In the first half of the year, the output value of Xinjiang pharmaceutical production enterprises increased by about 3.973 billion yuan year -on -year increased by 16.2%

On the production line of Xinjiang Uygur Pharmaceutical Co., Ltd., staff is performing digital control. Reporter Zhao Min Photo

Tianshan News (Reporter Zhao Min reported) The reporter learned from the Drug Administration of the Autonomous Region: In the first half of this year, the output value of drug production enterprises in our district was about 3.973 billion yuan, an increase of 16.2%year -on -year; 38.6%, the pharmaceutical industry in our district has developed rapidly.

Since the beginning of this year, the Autonomous Region Pharmaceutical Supervision and Administration Bureau has focused on the advantages of characteristic Chinese medicine ethnic medicine, formulated a series of guidelines for promoting the high -quality development of the Chinese medicine industry and high -quality development enterprises, and continuously improved its quality and efficiency. At the same time, it also gives full play to the advantages of Xinjiang, providing a strong guarantee for the development of the drug industry in our district.

In the first half of this year, our district continued to optimize the business environment and continued to deepen the reform of "decentralization of management service" to serve enterprises. At the same time, relying on the core area of ​​the Silk Road Economic Belt, the pharmaceutical industry enterprises in our district continued to open up the domestic and international markets and expanded The market and brand influence of Xinjiang's local pharmaceutical industry.

The relevant person in charge of the Drug Administration of the Autonomous Region said that in the next step, the drug supervision and management department of the autonomous region will continue to improve the ability and level of review approval, supervision and inspection, and law enforcement inspection, comprehensively use smart supervision and credit supervision to create "Digital Smart Drug Administration Supervision "New model, improve the predictability, pertinence and effectiveness of supervision work. On the premise of ensuring the quality and safety of drugs, continue to increase policy support, open up the" last mile "of the implementation of various relief and benefit enterprises policies, realize The pharmaceutical industry in our district has a higher quality development.

- END -